Skip to main content
. 2019 Oct 10;10(6):2153–2167. doi: 10.1007/s13300-019-00701-3

Fig. 3.

Fig. 3

Cost-effectiveness scatter plot of empagliflozin versus sitagliptin (a) and saxagliptin (b)